Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Jiangsu Province, China, with a focus on fluoroquinolone resistance

References

1. Belland R. J., Morrison S. G., Ison C., Huang W. M. 1994; Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 14:371–380 [CrossRef]
   [Google Scholar]
2. Cai C. J., Wu C. H., Lu S. C., Zhen H. P., Chen S. W., Liang L. H. 2003; Study on antibiotic resistance in Neisseria gonorrhoeae in Zhongshan city. Guangdong Medical J 24:1123–1124
   [Google Scholar]
3. Centers for Disease Control and Prevention 2005 Neisseria Gonorrhoeae reference strains for antimicrobial susceptibility testing pp. 10 Atlanta, GA: Centers for Disease Control and Prevention; http://www.cdc.gov/std/Gonorrhea/arg/B88-Feb-2005.pdf
   [Google Scholar]
4. Chaudhry U., Ray K., Bala M., Saluja D. 2002; Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India. Sex Transm Infect 78:440–444 [CrossRef]
   [Google Scholar]
5. Chinese Centre for Disease Control and Prevention; 2004; Chinese Centre for Disease Control and Prevention. Centre for Public Health Surveillance and Information Service. National data on class A and B infectious diseases in December, 2003. Disease Surveillance ( Beijing ) 19:3
   [Google Scholar]
6. Gu W. M., Yang Y., Wu L. & 7 other authors; 2004; Surveillance on antibiotic susceptibility of Neisseria Gonorrhoeae from 1988 to 2002 in Shanghai. Chin J Dermatol 37:323–325
   [Google Scholar]
7. Hawkey P. M. 2003; Mechanism of quinolone action and microbial response. J Antimicrob Chemother 51 (Suppl. S1):29–35 [CrossRef]
   [Google Scholar]
8. Krishna R., Manju B., Sudarshan K., Jai P. N. 2005; Antimicrobial resistance of Neisseria gonorrhoeae in selected World Health Organization Southeast Asia Region countries: an overview. Sex Transm Dis 32:178–184 [CrossRef]
   [Google Scholar]
9. National Committee for Clinical Laboratory Standards 2002 Performance Standard for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12 Wayne, PA: National Committee for Clinical Laboratory Standards;
   [Google Scholar]
10. Ng L. K., Sawatzky P., Martin I. E., Booth S. 2002; Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada. Sex Transm Dis 29:780–788 [CrossRef]
    [Google Scholar]
11. Shigemura K., Shirakawa T., Okada H. & 8 other authors; 2004; Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan. Sex Transm Dis 31:180–184 [CrossRef]
    [Google Scholar]
12. Shultz T. R., Tapsall J. W., White P. A. 2001; Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC. Antimicrob Agents Chemother 45:734–738 [CrossRef]
    [Google Scholar]
13. Su X. H. 2002; Drug resistance of gonococcus and treatment of gonorrhoeae. J Clin Dermatol 31:601–603
    [Google Scholar]
14. Su X., Lind I. 2001; Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrob Agents Chemother 45:117–123 [CrossRef]
    [Google Scholar]
15. Su X. H., Dai X. Q., Sun H. H., Ye S. Z. 2004; Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanjing City, 1999–2002. Chin J Dermatol 37:262–264
    [Google Scholar]
16. Tanaka M., Takahashi K., Saika T., Kobayashi I., Ueno T., Kumazawa J. 1998; Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan. J Urol 159:2215–2219 [CrossRef]
    [Google Scholar]
17. Tanaka M., Nakayama H., Haraoka M., Saika T. 2000; Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993–1998. J Clin Microbiol 38:521–525
    [Google Scholar]
18. Tanaka M., Nakayama H., Notomi T., Irie S., Tsunoda Y., Okadome A., Saika T., Kobayashi I. 2004; Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993–2002: continuous increasing of ciprofloxacin-resistant isolates. Int J Antimicrob Agents 24 (Suppl. 1):S15–S22 [CrossRef]
    [Google Scholar]
19. Trees D. L., Sandul A. L., Peto-Mesola V., Aplasca M. R., Leng H. B., Whittington W. L., Knapp J. S. 1999; Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States. Int J Antimicrob Agents 12:325–332 [CrossRef]
    [Google Scholar]
20. World Health Organization 2003; Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002. Commun Dis Intell 27:488–491
    [Google Scholar]
21. Ye S. Z. 2001; Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae isolated from ten cities of China from 1993–1998. Chin J Dermatol 34:175–177
    [Google Scholar]
22. Yong D., Kim T. S., Choi J. R., Yum J. H., Lee K., Chong Y., Oh H. B., Shultz T., Tapsall J. W. 2004; Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neiserria gonorrhoeae strains isolated in Korea and nearby countries. J Antimicrob Chemother 54:451–455 [CrossRef]
    [Google Scholar]
23. Yoo J., Yoo C., Cho Y., Park H., Oh H. B., Seong W. K. 2004; Antimicrobial resistance patterns (1999–2002) and characterization of ciprofloxacin-resistant Neisseria gonorrhoeae in Korea. Sex Transm Dis 31:305–310 [CrossRef]
    [Google Scholar]
24. Zhu B. Y., Zhao X. M. 2003; The analysis of antibiotic resistance in Neisseria gonorrhoeae . J Clin Dermatol 32:199–200
    [Google Scholar]